Corris Paul A
University of Newcastle upon Tyne and Regional Cardiothoracic Centre, Freeman Hospital, High Heaton, Newcastle upon Tyne NE7 7DN, UK.
Chest Surg Clin N Am. 2003 Aug;13(3):543-57. doi: 10.1016/s1052-3359(03)00052-8.
BOS remains a difficult problem to control following lung transplantation, largely because of uncertainties regarding the underlying mechanisms that are responsible for it. Continued work on the pathogenesis of BOS is essential. The progressive nature and poor outlook when BOS stage 3 is reached indicates that current strategies should be focused on prevention and early intervention. There is a great need for randomized, controlled trials on intervention if the international transplant community is to make progress in this area.
移植后闭塞性细支气管炎(BOS)仍然是一个难以控制的问题,这主要是因为其潜在发病机制存在不确定性。对BOS发病机制的持续研究至关重要。BOS进展到3期时的渐进性本质和不良预后表明,当前策略应侧重于预防和早期干预。如果国际移植界要在这一领域取得进展,就非常需要进行关于干预的随机对照试验。